AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesAnthropology, Education, Sociology and Social PhenomenaInformation ScienceNamed GroupsHealth Care
Bone Marrow TransplantationTransplantation, AutologousTransplantation, HomologousBone MarrowHematopoietic Stem Cell TransplantationBone Marrow CellsTransplantation ConditioningGraft vs Host DiseaseWhole-Body IrradiationBone and BonesRecurrenceGraft SurvivalAnemia, AplasticKidney TransplantationTissue DonorsTreatment OutcomeLeukemiaTransplantation ChimeraLiver TransplantationHodgkin DiseaseHematopoietic Stem Cell MobilizationBone Marrow PurgingMultiple MyelomaBusulfanHistocompatibility TestingSurvival AnalysisRetrospective StudiesHistocompatibilityHematopoietic Stem CellsCyclophosphamideGraft RejectionTransplantation, IsogeneicImmunosuppressive AgentsBone Marrow DiseasesCombined Modality TherapyHematopoiesisHeart TransplantationTime FactorsMice, Inbred C57BLLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraHematologic NeoplasmsRemission InductionStem Cell TransplantationImmunosuppressionTransplantation ImmunologyBone Marrow ExaminationPrecursor Cell Lymphoblastic Leukemia-LymphomaLung TransplantationHepatic Veno-Occlusive DiseaseLymphoma, Non-HodgkinBone RemodelingLeukemia, MyeloidAcute DiseaseBone Marrow NeoplasmsGraft vs Host ReactionT-LymphocytesLymphocyte DepletionCyclosporineLeukocyte TransfusionHLA AntigensColony-Forming Units AssaySevere Combined ImmunodeficiencyMyelodysplastic SyndromesChimeraAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesActuarial AnalysisCarmustineCytomegalovirus InfectionsHematologic DiseasesLymphocyte TransfusionMelphalanSurvival RateTransplantationBone DensityTransplantsCytarabineNuclear FamilyCell DifferentiationGraft vs Tumor EffectDisease-Free SurvivalLeukocyte CountGranulocyte Colony-Stimulating FactorEtoposideOrgan TransplantationPancytopeniaGraft vs Leukemia EffectFlow CytometryLymphomaCells, CulturedSpleenPostoperative ComplicationsMice, Inbred BALB CCell TransplantationAntigens, CD34Peripheral Blood Stem Cell TransplantationFatal OutcomeLiving Donors
DonorStem cellUses the patient's own stem cellsGranulocyte-macropPatient's own bone marrowHaploidenticalMultiple MyelomaGraft-versus-Effects of Bone Marrow TransplaAllogenicUmbilicalHarvested from the patient'sHSCTASCTHematologyBiopsyPatientsClonal plasma cellsRadiationTherapeuticHigh-doseProgenitor cellSurvivalProcedureLymphatic systemHematologic malignanciesCellsRegimenType of transplantLeukemiasDiseasesPediatricInfusionAbstractLeukemiaRegimens2016Cord bloodChemotherapy followedOrgan dysfunctionImmuneHospitalTreatmentMalignancyTherapiesCentreBlood cancersTolerateClinical
Donor20
  • The most common type of BMT performed to treat AML, allogeneic transplantation involves the use of healthy blood-forming cells obtained from a compatible donor. (moffitt.org)
  • Autologous bone marrow transplantation may be an option for a patient who does not have a compatible donor. (moffitt.org)
  • As a National Marrow Donor Program (NMDP) transplant and collection center, we are fully accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). (moffitt.org)
  • In a single location, our patients can benefit from comprehensive diagnostic, donor matching, bone marrow transplant and supportive care services. (moffitt.org)
  • The cells for transplantation can come from your own body (autologous) or a donor (allogeneic). (mhs.net)
  • An initial appointment was scheduled for 22 March 2020 at An-Najah Hospital in Nablus, in the West Bank, but the hospital only offers autologous transplantation (using the patient's own bone marrow), while Saja needed an allogeneic transplant (with bone marrow from a donor). (who.int)
  • In an allogeneic transplant the stem cells are donated from another person, who is a genetically-matched stem cell donor. (leukaemia.org.au)
  • Additionally, all patients without a sibling donor in complete remission after the first consolidation course were randomized to either autologous peripheral blood stem cell transplantation or a second consolidation course consisting of high-dose cytarabine. (haematologica.org)
  • Conclusions Patients with a donor and candidates for allogeneic stem cell transplantation in first complete remission may have a better disease-free survival than those without a donor in case of myelodysplastic syndromes with intermediate/high-risk cytogenetics. (haematologica.org)
  • 6 - 8 However, the outcome of autologous peripheral blood SCT for patients lacking a suitable donor, appeared, in some studies, comparable to that of allogeneic SCT. (haematologica.org)
  • Allogeneic transplant This approach uses stem cells from a related donor, unrelated matched donor or half-matched related (haploidentical) donor. (ucsd.edu)
  • Donor lymphocyte infusions (DLI) These harness the patient's immune system to fight cancer that recurs after transplantation. (ucsd.edu)
  • 2) Once the opinion is received, Sharing of passport details along with passport details of the donor in case of an allogenic bone marrow transplant to get the Visa Invitation Letter from the treating hospital. (ghnservices.com)
  • Training for Transfusion Medicine support of stem cell transplantation programs is obtained through the Bone Marrow Transplant Program at Michigan Medicine, which is university-based program providing autologous, related and unrelated stem cell transplants under certification of the National Marrow Donor Program. (beaumont.edu)
  • The cells may be from the patient (autologous) or from a donor (allogenic). (nih.gov)
  • Allogeneic transplants require a matching donor with respect to the tissue or HLA matching. (bloodcancercure.com)
  • There are different types of allogeneic transplants available based on the donor cells source. (bloodcancercure.com)
  • Fasano R, Mamcarz E , Adams S, Donohue Jerussi T, Sugimoto K, Tian X, Flegel W, Childs R. HLA antibody persistence and de novo production of donor origin following reduced intensity allogeneic hematopoietic stem cell transplantation. (stjude.org)
  • The blood-forming stem cells can come either from the patient (called an autologous SCT) or from a donor (called an allogeneic SCT). (cancer.org)
  • In an allogeneic SCT, the stem cells for the transplant come from someone else (a donor). (cancer.org)
Stem cell50
Uses the patient's own stem cells2
  • An autologous transplant uses the patient's own stem cells, collected in advance and returned to them after they receive high doses of chemotherapy. (leukaemia.org.au)
  • Autologous transplant This approach uses the patient's own stem cells. (ucsd.edu)
Granulocyte-macrop2
Patient's own bone marrow1
Haploidentical1
Multiple Myeloma6
Graft-versus-4
  • Additionally, because the patient receives his or her own bone marrow cells, the procedure may be easier to tolerate and the risk of certain complications, such as graft-versus-host disease, is minimized. (moffitt.org)
  • In addition to complications seen from exposure to chemotherapy and radiation, patients undergoing allogeneic transplantation can experience unique late effects secondary to graft versus host disease (GVHD) and autoimmunity. (medscape.com)
  • If your child received bone marrow from someone else, look for signs of graft-versus-host disease ( GVHD ). (medlineplus.gov)
  • These transplants are prone to certain complications like graft-versus-host disease and other complications like graft failure, complete rejection etc. (bloodcancercure.com)
Effects of Bone Marrow Transpla1
Allogenic1
  • Aetna considers tandem autologous hematopoietic cell transplantion (auto-auto) or tandem autologous hematopoietic cell transplantation followed by allogenic hematopoietic cell transplantation (auto-allo) experimental and investigational for NHL due to a lack of adequate evidence in the peer-reviewed published medical literature of their safety and effectiveness. (aetna.com)
Umbilical1
  • Cord blood transplant This uses stem cells from the umbilical cord blood or placenta of healthy newborns. (ucsd.edu)
Harvested from the patient's1
  • the main difference is that the bone marrow cells used for the procedure are harvested from the patient's own body instead of a donor's body. (moffitt.org)
HSCT3
  • Participants in these earlier trials received non-myeloablative HSCT, a less intensive procedure using lower doses of chemotherapy that does not completely destroy the bone marrow. (nih.gov)
  • Participants in the SCOT trial, conducted at 26 clinical research sites in the United States and Canada, were randomly assigned to receive either myeloablative autologous HSCT or one year of treatment with monthly doses of intravenous cyclophosphamide. (nih.gov)
  • This is a quantitative, retrospective, observational, descriptive and analytical quantitative approach approaching the medical records of children and adolescents submitted to HSCT in a referral hospital service for this type of transplantation in the state of Rio Grande do Sul North (RN). (bvsalud.org)
ASCT2
  • In newly diagnosed myeloma patients, upfront autologous transplant (ASCT) prolongs progression-free survival 1 (PFS1) compared with chemotherapy plus lenalidomide (CC+R). Salvage ASCT at first relapse may still effectively rescue patients who did not receive upfront ASCT. (nih.gov)
  • The Intergroupe Francophone du Myelome 3 was the first to demonstrate, in a large randomized trial, the long-term benefits in survival of double ASCT in comparison with single transplants. (haematologica.org)
Hematology3
  • 11 Hematology and Bone Marrow Transplantation Unit, IRCCS San Martino-Ist, Genova, Italy. (nih.gov)
  • Beginning July 2020, Dr. Qasrawi joined the Division of Hematology, Bone Marrow Transplantation & Cellular Therapy at the University of Kentucky where he primarily sees patients with myeloid malignancies including acute myeloid leukemia, myelodysplastic syndromes, chronic myeloid leukemia, and myeloproliferative disorders. (uky.edu)
  • Beaumont Hospital, Royal Oak is a 1,131 bed facility, which has an active transfusion service supporting a Level 1 Trauma Center, an expanding solid organ transplant program, and busy OB/GYN and hematology/oncology services. (beaumont.edu)
Biopsy1
  • The technique, known as MinimuM-seq, has the potential to replace a bone marrow biopsy as the standard method of screening for conditions that often precede myeloma and of determining the extent of the disease. (dana-farber.org)
Patients30
  • To accomplish this, some patients receive a bone marrow transplant (BMT). (moffitt.org)
  • Even so, autologous bone marrow transplants are used less frequently than allogeneic transplants for AML patients, mainly due to the risk of returning some leukemia cells to the patient, and also because the procedure does not produce a GVL effect. (moffitt.org)
  • On the basis of these studies, it has been proposed that bone marrow-derived adult stem cells may be exploited for cardiac tissue repair and regeneration in patients after AMI. (medscape.com)
  • The present study was a randomized controlled trial designed to determine the impact of intracoronary autologous BMC transfer on LV remodeling and functional regeneration in patients after AMI and successful percutaneous coronary intervention (PCI). (medscape.com)
  • Sixty-five patients received rhGM-CSF in a two-hour intravenous infusion daily for 21 days, starting within four hours of the marrow infusion, and 63 patients received placebo. (nih.gov)
  • [ 7 ] of 798 patients who survived more than 5 years after transplantation, 328 were children. (medscape.com)
  • high-risk patients included male subjects, recipients of stem cells from female donors, patients younger than 10 years, those with nonidentical donors, and those who received radiation therapy in the transplant preparative regimen. (medscape.com)
  • [ 2 , 8 ] Survivors of bone marrow transplantation were more likely to have a severe or life threatening condition (relative risk [RR] = 3.9), more than one chronic condition (RR = 2.6), functional impairment (RR=3.5), and activity limitations (RR = 5.8) than conventionally treated patients. (medscape.com)
  • this should lead to better overall survival in both transplant and non-transplant patients. (medscape.com)
  • With the introduction of high-dose cytarabine, intensification of induction therapy, and consolidation with autologous transplant, responses and disease-free intervals have improved for patients with previously untreated MCL. (cancernetwork.com)
  • Because hematopoiesis is temporarily discontinued until after engraftment in patients undergoing myeloablation prior to transplant, nearly all would experience life-threatening anemia without RBC transfusion. (webharvest.gov)
  • We report here the hematologic and immunologic changes observed in the first 10 patients of a phase 1 trial studying the infusion of IL-2 after autologous BMT. (ashpublications.org)
  • All patients had high-risk malignancies and received 6 days of a constant infusion of IL-2 (Eurocetus, Amsterdam, The Netherlands) at dose of 3 x 10(6) Cetus Units/m2/d, 79 +/- 12 days after autologous BMT. (ashpublications.org)
  • Reduced-intensity allogeneic transplant It involves a lower dose of chemotherapy or radiation to safely treat older and more fragile patients. (ucsd.edu)
  • Some patients may be able to receive their transplant on an outpatient basis at Moores Cancer Center in La Jolla. (ucsd.edu)
  • Designed with input from patients and family, the BMT unit at Jacobs Medical Center offers unparalleled comfort and freedom of movement for those recovering from a blood or marrow transplant. (ucsd.edu)
  • Due to above factors, patients in large number from all over the globe prefer to travel to Indian hospitals for bone marrow transplant. (ghnservices.com)
  • The procedure require special arrangements like Special BMT suites to keeping the patients away from any kind of infection, experienced and trained nurses, experienced team of doctors and exclusive arrangements for handling bone marrow transplant patients. (ghnservices.com)
  • However, even in patients with chemotherapy-sensitive DLBCL, relapse of lymphoma is a major cause of transplantation failure. (nih.gov)
  • Therefore, the BMT CTN 0401 trial was initiated to test the primary hypothesis that the addition of 131 I-tositumomab to a standard high-dose chemotherapy transplantation regimen with BEAM would improve the 2-year progression-free survival compared with the addition of rituximab to the same chemotherapy transplantation protocol in patients with chemotherapy-sensitive persistent or relapsed DLBCL. (nih.gov)
  • Patients also needed ≤ 20% involvement of their bone marrow with lymphoma with no evidence of myelodysplastic syndrome in the pretransplantation bone marrow. (nih.gov)
  • Inherent flaws with this technique known as autologous Chondrocyte implantation, led to cartilage overgrowth in some cases, and an aging effect of the lab grown cells rendering their use limited to basically patients under 50. (moneyfocus.com)
  • Nowadays, besides palliative care for the treatment or alleviation of symptoms, bone marrow transplantation is the only therapeutic option for patients affected by fucosidosis. (pdf-archive.com)
  • These findings suggest that abnormalities in PFTs are common in the first months after BMT in pediatric patients but are not consistently associated with impairment of lung function when studied 15 months post‐transplant.Pediatr Pulmonol. (johnshopkins.edu)
  • LEUKINE is indicated for acceleration of myeloid recovery in patients with non-Hodgkin's lymphoma (NHL), acute lymphoblastic leukemia (ALL) and Hodgkin's disease undergoing autologous bone marrow transplantation (BMT). (druglib.com)
  • After autologous BMT in patients with NHL, ALL, or Hodgkin's disease, LEUKINE has been found to be safe and effective in accelerating myeloid engraftment, decreasing median duration of antibiotic administration, reducing the median duration of infectious episodes and shortening the median duration of hospitalization. (druglib.com)
  • LEUKINE is indicated in patients who have undergone allogeneic or autologous bone marrow transplantation (BMT) in whom engraftment is delayed or has failed. (druglib.com)
  • LEUKINE has been found to be safe and effective in prolonging survival of patients who are experiencing graft failure or engraftment delay, in the presence or absence of infection, following autologous or allogeneic BMT. (druglib.com)
  • Survival benefit may be relatively greater in those patients who demonstrate one or more of the following characteristics: autologous BMT failure or engraftment delay, no previous total body irradiation, malignancy other than leukemia or a multiple organ failure (MOF) score ≤ two (see CLINICAL EXPERIENCE ). (druglib.com)
  • Autologous transplants can help some people with WM, but doctors are still trying to figure out which patients will benefit the most. (cancer.org)
Clonal plasma cells1
  • Immunoglobulin amyloid light-chain (AL) amyloidosis is the most common form of systemic amyloidosis, where the culprit amyloidogenic protein is immunoglobulin light chains produced by marrow clonal plasma cells. (karger.com)
Radiation3
  • The procedure began with doctors collecting a participant's blood-forming stem cells, after which the participant received chemotherapy and radiation to eliminate the bone marrow. (nih.gov)
  • These stem cells are kept in freezer and are preserved which are in later time induced into the bone marrow of the patient after Chemotherapy & radiation. (ghnservices.com)
  • Every type of bone marrow transplant (BMT) is available in India and the hospitals are fully equipped with all necessary equipment like a proper radiation and oncology unit for total body radiation, and chemotherapy drugs and equipments. (bloodcancercure.com)
Therapeutic1
  • New clinical trial findings show that a therapeutic regimen involving transplantation of a person's own blood-forming stem cells can improve survival and quality of life for people with severe scleroderma, a life-threatening autoimmune disease. (nih.gov)
High-dose3
  • Bone marrow transplant (BMT) is an approach of giving very high dose chemotherapy, sometimes with whole body radiotherapy. (yashodahospitals.com)
  • Previous research has established the use of high-dose chemotherapy with autologous bone marrow transplantation as the standard of care for relapsed chemotherapy-sensitive diffuse large B-cell lymphoma (DLBCL). (nih.gov)
  • Bexxar has been used in several Phase I and II transplant trials either alone or in combination with high-dose chemotherapy for the treatment of relapsed non-Hodgkin's lymphoma. (nih.gov)
Progenitor cell1
Survival3
  • For others a transplant is the only option that offers a prospect of cure, or long-term survival. (leukaemia.org.au)
  • 2 The International Prognostic Scoring System (IPSS) 3 distinguishes four risk groups for survival and AML evolution based on cytogenetic subgroups, percentage of bone marrow blasts and number of cytopenias. (haematologica.org)
  • The economical pricing of bone marrow transplant (BMT) procedure with a good survival rate and success rate offered by the Indian hospitals has led to this change. (bloodcancercure.com)
Procedure2
Lymphatic system4
Hematologic malignancies1
Cells45
Regimen3
  • The SCOT trial assessed a myeloablative transplant regimen, which researchers thought might offer better long-term outcomes. (nih.gov)
  • Aetna considers non-myeloablative allogeneic hematopoietic cell transplantation medically necessary ("mini-transplant", reduced intensity conditioning transplant) for the treatment of persons with relapsed NHL (including persons who have relapsed after ABMT) or primary refractory (see note below) NHL (low-grade, intermediate-grade, and high-grade) when they are eligible for conventional allografting or a reduced intensity regimen is preferred by the transplant center. (aetna.com)
  • The additional administration of monoclonal antibodies (rituximab) to the mobilization and conditioning regimen is the standard of care at most transplant centers. (nih.gov)
Type of transplant3
  • The type of transplant you are given depends on a number of factors. (leukaemia.org.au)
  • The cost of bone marrow transplant in India ranges from USD 15000- 45000 depending on the type of transplant is needed by the patient. (ghnservices.com)
  • Patient & the direct Siblings are required to undergo HLA typing investigations to find out the suitable match for this type of Transplant. (ghnservices.com)
Leukemias1
  • Several diseases like bone marrow disorders, leukemias, lymphomas, aplastic anemia sickle cell anemia, multiple myelomas, thalassemia, pediatric tumors etc can be treated by bone marrow transplant (BMT). (bloodcancercure.com)
Diseases5
  • This Request for Applications (RFA), Mechanisms of Post Bone Marrow Transplantation Lung Injury, is related to the priority areas of immunization and infectious diseases and cancer. (nih.gov)
  • Dr. B Chandrasekhar, Clinical Hematologist, Hemato-Oncologist and Bone marrow Transplant Physician explaining in detail about blood-related diseases and the Bone marrow Transplantation treatments. (visakhapatnamdoctors.com)
  • National Institute of Blood Diseases & Bone Marrow Transplantation (NIBD & BMT) Karachi and Lahore, Pakistan. (edu.pk)
  • range, 4-15) who received allogeneic (n = 14) or autologous (n = 11) BMT for neoplastic diseases at The Johns Hopkins Hospital. (johnshopkins.edu)
  • The Institute's research portfolio includes five core mission areas: Arthritis and Rheumatic Diseases, Skin Biology and Diseases, Bone Biology and Diseases, Muscle Biology and Diseases, and Musculoskeletal Biology and Diseases. (nih.gov)
Pediatric2
  • In a study from the United States, long-term survivors of pediatric bone marrow transplantation followed in the Bone Marrow Transplant Survivors Study were compared with survivors of childhood cancer treated without bone marrow transplant from the Childhood Cancer Survivor Study. (medscape.com)
  • To stimulate and facilitate further research, the NCI and NHLBI held the First International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation on April 28 and 29, 2011. (medscape.com)
Infusion1
  • Learn about the blood and bone marrow transplant process, from evaluation to infusion. (ucsd.edu)
Abstract1
Leukemia1
Regimens3
  • The clinical trial, called Scleroderma: Cyclophosphamide or Transplantation (SCOT), compared the safety and potential benefits of the two treatment regimens among 75 people with diffuse systemic sclerosis who had lung or kidney involvement. (nih.gov)
  • However, neither trial changed clinical practice in the United States, in part because of concerns about the durability of responses to treatment and the safety of these transplant regimens. (nih.gov)
  • Despite improvements in frontline management strategies, including the incorporation of cytarabine, intensification of chemotherapeutic regimens, and consolidation with transplant, MCL remains incurable. (cancernetwork.com)
20161
  • Bone Marrow Transplant Jun:51:1533-1536, 2016. (stjude.org)
Cord blood1
Chemotherapy followed1
  • 6 , 9 , 10 Moreover, a retrospective study comparing intensive chemotherapy alone against chemotherapy followed by transplantation did not show a clear benefit for chemotherapy followed by SCT. (haematologica.org)
Organ dysfunction1
  • No evidence of serious organ dysfunction based upon the transplanting institution's evaluation. (aetna.com)
Immune3
  • NIH-funded study finds transplantation superior to treatment with immune-suppressing drug. (nih.gov)
  • Use of recombinant Interleukin-2 (rIL-2) after autologous bone marrow transplantation (BMT) may enhance immune function and hopefully reproduce the allogeneic reaction. (ashpublications.org)
  • This study establishes the feasibility of a 6-day administration of rIL- 2 after autologous BMT leading to a major immune activation 2.5 months after BMT. (ashpublications.org)
Hospital5
  • Saja was rescheduled an appointment at Augusta Victoria Hospital in East Jerusalem, but again the hospital could only offer autologous transplantation. (who.int)
  • Throughout efforts to refer Saja for bone marrow transplant, she has been receiving chemotherapy at Rantisi Hospital in Gaza City. (who.int)
  • Hello Everyone, If you have a loved who is suffering from a disease that requires bone marrow transplant then searching for cheapest bone marrow transplant in india is a very common as this treatment is expensive and the reason for that is, the patient requiring long hospital stay, use expensive anti cancer medications , continuous observation by doctors and nurses and continuous investigation to check the status of the patient. (ghnservices.com)
  • National Institute of Blood Disease & Bone Marrow Transplantation is an 140 bed Hospital in the heart of the city of Karachi. (edu.pk)
  • Every hospital or center offering bone marrow transplant in India is facilitated with ultra-modern infrastructure along with widely experienced and even some internationally trained doctors and staff. (bloodcancercure.com)
Treatment6
  • She needs a bone marrow transplant, not available in the Gaza Strip, and has not been able to access the treatment she needs since March 2020. (who.int)
  • Saja received her initial chemotherapy in Rabat, before returning home to Gaza in February 2020 to continue her treatment and undergo bone marrow transplantation in the occupied Palestinian territory. (who.int)
  • Anemia caused by occult bleeding, hemolysis, marrow replacement, or a nutritional deficiency is unlikely to respond to epoetin treatment but may be corrected using other therapies. (webharvest.gov)
  • Aetna considers autologous hematopoietic cell transplantation for the treatment of persons with relapsed or primary refractory (see "Note" below) non-Hodgkin's lymphoma (NHL) medically necessary if the person meets the transplanting institution's protocol eligibility criteria. (aetna.com)
  • Aetna considers allogeneic hematopoietic cell transplantation medically necessary for the treatment of persons with relapsed NHL (including persons who have relapsed after autologous hematopoietic cell transplantation) or primary refractory (see "Note" below) NHL (low-grade, intermediate-grade, and high-grade) if the person meets the transplanting institution's protocol eligibility criteria. (aetna.com)
  • The treatment in western countries is so expensive that it is beyond the reach of common man who is not insured, so for bone marrow transplant, India is the best and most suitable choice from people all over the world. (ghnservices.com)
Malignancy1
  • The malignancy occurs after a single bone marrow cell undergoes an abnormal change that affects its DNA, which provides the cell with specific instructions on how to behave, including when to grow, reproduce and die. (moffitt.org)
Therapies1
Centre1
Blood cancers1
Tolerate1
  • The transplant process is demanding both physically and emotionally, and some people may not be fit enough to tolerate it. (leukaemia.org.au)
Clinical2
  • This Clinical Policy Bulletin addresses hematopoietic cell transplantation for non-hodgkin's lymphoma. (aetna.com)
  • Our joint BMT program was one of the charter members of the prestigious Blood and Marrow Transplant Clinical Trials Network, the premier BMT clinical trials group in the world. (ucsd.edu)